Intuitive Surgical (ISRG) Stock Rating Upgraded by Piper Jaffray Companies

Share on StockTwits

Piper Jaffray Companies upgraded shares of Intuitive Surgical (NASDAQ:ISRG) to an overweight rating in a research report report published on Wednesday morning, The Fly reports. They currently have $610.00 target price on the medical equipment provider’s stock.

A number of other equities analysts have also recently issued reports on ISRG. Stifel Nicolaus dropped their price objective on Intuitive Surgical from $600.00 to $570.00 and set a buy rating for the company in a report on Friday, January 25th. Cantor Fitzgerald restated a buy rating and set a $620.00 price objective on shares of Intuitive Surgical in a report on Friday, January 25th. BidaskClub cut Intuitive Surgical from a strong-buy rating to a buy rating in a report on Wednesday, January 30th. Zacks Investment Research cut Intuitive Surgical from a buy rating to a hold rating in a report on Wednesday, January 30th. Finally, Royal Bank of Canada set a $560.00 price objective on Intuitive Surgical and gave the company a hold rating in a report on Thursday, February 28th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and thirteen have issued a buy rating to the company’s stock. Intuitive Surgical presently has a consensus rating of Buy and an average price target of $576.82.

ISRG opened at $476.53 on Wednesday. Intuitive Surgical has a 52-week low of $430.24 and a 52-week high of $589.32. The firm has a market cap of $55.01 billion, a P/E ratio of 50.21, a price-to-earnings-growth ratio of 4.22 and a beta of 1.02.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.70 by ($0.09). Intuitive Surgical had a net margin of 29.78% and a return on equity of 17.33%. The business had revenue of $974.00 million for the quarter, compared to analysts’ expectations of $975.27 million. During the same quarter in the previous year, the firm earned $2.44 EPS. Intuitive Surgical’s revenue was up 14.9% compared to the same quarter last year. As a group, equities analysts expect that Intuitive Surgical will post 9.4 earnings per share for the current year.

In other Intuitive Surgical news, Director Lonnie M. Smith sold 210 shares of the company’s stock in a transaction on Tuesday, February 26th. The stock was sold at an average price of $546.56, for a total value of $114,777.60. Following the completion of the sale, the director now directly owns 359,246 shares in the company, valued at approximately $196,349,493.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Lonnie M. Smith sold 227 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $493.39, for a total value of $111,999.53. Following the completion of the sale, the director now owns 359,696 shares of the company’s stock, valued at $177,470,409.44. The disclosure for this sale can be found here. Insiders sold a total of 28,619 shares of company stock valued at $14,444,692 over the last quarter. Company insiders own 1.70% of the company’s stock.

Hedge funds have recently modified their holdings of the business. Cerebellum GP LLC lifted its stake in shares of Intuitive Surgical by 10.1% during the 1st quarter. Cerebellum GP LLC now owns 598 shares of the medical equipment provider’s stock worth $341,000 after purchasing an additional 55 shares during the last quarter. Advisory Services Network LLC lifted its stake in shares of Intuitive Surgical by 2.8% during the 1st quarter. Advisory Services Network LLC now owns 7,876 shares of the medical equipment provider’s stock worth $4,494,000 after purchasing an additional 213 shares during the last quarter. Nordea Investment Management AB lifted its stake in shares of Intuitive Surgical by 221.8% during the 1st quarter. Nordea Investment Management AB now owns 21,140 shares of the medical equipment provider’s stock worth $12,065,000 after purchasing an additional 14,571 shares during the last quarter. Horizon Investments LLC purchased a new stake in shares of Intuitive Surgical during the 1st quarter worth $269,000. Finally, Merit Financial Group LLC lifted its stake in shares of Intuitive Surgical by 10.3% during the 1st quarter. Merit Financial Group LLC now owns 727 shares of the medical equipment provider’s stock worth $414,000 after purchasing an additional 68 shares during the last quarter. Institutional investors and hedge funds own 85.35% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Featured Story: Trading Ex-Dividend Strategy

The Fly

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Barry Zwarenstein Sells 7,663 Shares of Five9 Inc  Stock
Barry Zwarenstein Sells 7,663 Shares of Five9 Inc Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc  Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc Stock
Insider Selling: Neogen Co.  Director Sells 5,000 Shares of Stock
Insider Selling: Neogen Co. Director Sells 5,000 Shares of Stock
Neogen Co.  Director Sells $314,650.00 in Stock
Neogen Co. Director Sells $314,650.00 in Stock
Insider Selling: Airgain Inc  CEO Sells 22,464 Shares of Stock
Insider Selling: Airgain Inc CEO Sells 22,464 Shares of Stock
Insider Selling: Bottomline Technologies  Insider Sells 9,925 Shares of Stock
Insider Selling: Bottomline Technologies Insider Sells 9,925 Shares of Stock


© 2006-2019 Ticker Report